BFLY241220C2000
- 1.35
- +0.05+3.85%
Butterfly Network Newsroom
Lake Street Maintains Butterfly Network(BFLY.US) With Buy Rating, Maintains Target Price $3
TD Cowen Maintains Butterfly Network(BFLY.US) With Buy Rating, Maintains Target Price $3
Lake Street Maintains Butterfly Network(BFLY.US) With Buy Rating, Maintains Target Price $3
TD Cowen Maintains Butterfly Network(BFLY.US) With Buy Rating, Maintains Target Price $3
Buy Rating Affirmed: Butterfly Network's AI Integration Sets Stage for Market Differentiation and Growth
Butterfly Network Analyst Ratings
Lake Street Initiates Butterfly Network(BFLY.US) With Buy Rating, Announces Target Price $3
Lake Street Initiates Butterfly Network at Buy With $3 Price Target
TD Cowen Maintains Butterfly Network(BFLY.US) With Buy Rating, Maintains Target Price $3
Oppenheimer Keeps Their Buy Rating on Butterfly Network (BFLY)
Oppenheimer Maintains Butterfly Network(BFLY.US) With Buy Rating, Maintains Target Price $3.75
TD Cowen Maintains Butterfly Network(BFLY.US) With Buy Rating, Maintains Target Price $3
Buy Rating Affirmed: Butterfly Network's Impressive Sales and Strong Growth Trajectory
Buy Rating Affirmed: Butterfly Network's Growth and Innovation With IQ+ Bladder Launch
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Butterfly Network (BFLY) and Deciphera Pharmaceuticals (DCPH)
Butterfly Network (BFLY) Receives a Buy From Oppenheimer
Buy Rating Justified: Butterfly Network's Growth Strategy and Innovative Product Roadmap
Butterfly Network (BFLY) Receives a Buy From Oppenheimer
Analysts Have Conflicting Sentiments on These Healthcare Companies: Butterfly Network (BFLY) and Codexis (CDXS)
Oppenheimer Keeps Their Buy Rating on Butterfly Network (BFLY)